New Data suggest COVAXIN (BBV152) may provide protection against current and future variants!
data from a Phase 3 trial that included nearly 25,800 participants: 77.8% overall efficacy, 93.4% efficacy against severe illness and 65.2% efficacy against the Delta variant.
the way this keeps dipping is bad do you guys really think this is possible i mean by last year i would think it looks due for another spike but just keeps goig down even with good news
@CryptoFundManager ThankYou will keep eye tomorrow.
StarWeek143
⋅
@CryptoFundManager it have to break 6.80 to reach 9 is that not right? m still learning charts so not that expert like you. But will surely hope and wish it reach 10